Europe OTC Drugs Industry size to hit USD 36.65 Bn by 2021Posted by rohan on October 14th, 2017 According to the report Europe OTC drugs Industry, published by Market Data Forecast, The Industry in Europe has been estimated at USD 26.34 billion in 2016 and is projected to reach USD 36.65 billion by 2021, at a CAGR of 6.83% during the forecast period from 2016 to 2021. OTC drugs are the safe and effective drugs used for common ailments, and can be bought at the pharmacies and local stores, over the counter, without doctor’s prescription. Acetaminophen, aspirin and ibuprofen are the most common OTC drugs. Easy accessibility, low cost, convenience, customer-empowering qualities are the benefiting the OTC drugs Industry in Europe. Browse Industry data tables and in-depth TOC of the Europe Over the Counter (OTC) Drugs Industry to 2021 @ http://www.marketdataforecast.com/market-reports/europe-over-the-counter-drugs-market-511/ In Europe, public started showing pro-active approach towards the ailments and are resorting to lower-priced alternatives due to raising costs in healthcare. The cultural shift in public towards self-reliance is helping the pharma firms gain major acquisitions. These are some of the drivers that are fueling the Industry growth. The Industry growth is hindered majorly due to the issue of drug substance abuse. The European Industry is segmented based on product and geographically. The product Industry basically caters medicines in the categories like analgesics, cough, cold and flu products, dermatological products, gastrointestinal products, vitamins, minerals, weight loss products, sleep aids, ophthalmic products, smoking cession aids and other products. More than half of the Industry share belongs to categories like Analgesics, Cough, Cold & Flu, Dermatological and gastrointestinal categories. Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-over-the-counter-drugs-market-511/request-sample In the EU, the major contributors to the Industry are Germany and France. Annual growth for developed nations is decreasing, while for the developing nations like Poland, the growth is stable. Ukraine and Bulgaria are the most rapidly developing Industrys. The governments in the EU are attempting to shift the costs to customers and are trying to save doctors’ and pharmacists’ resource costs. GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda and are the top companies that contribute to North American OTC drugs Industry. Loss of patent protection is leading the companies switch to OTC. Key Points from Table of Contents Overview
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) Europe OTC Drugs Industry: Segmentation
Geographical Analysis
Strategic Analysis
Industry Leaders' Analysis Competitive Landscape About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail:abhishek@marketdataforecast.com Like it? Share it! More by this author |